Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » Abstracts

Abstracts

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 10/07/19 by Fiona MacLean

Investigation of community pharmacists’ input to the pharmaceutical care of patients prescribed systemic anticancer therapy Results of a focus group and questionnaire.

Abstracts

View resources
Last reviewed: 10/07/19 by Sumantha Gabriel

Pre-hydration in High Dose Methotrexate Chemotherapy

Abstracts

View resources
Last reviewed: 10/07/19 by Nicola Stoner

Patient satisfaction with a clinical pharmacy service to chemotherapy day treatment units

Abstracts

View resources
Last reviewed: 09/02/23 by Faouzi Djebbari

Service evaluation of a myeloma pharmacist non-medical prescribing (NMP) service

Abstracts

View resources
Last reviewed: 10/07/19 by Joseph Williams

Preliminary results of a Specialist Pharmacist led Medicines Optimisation Service (Polypharmacy clinic) for Prostate Cancer patients

Abstracts

View resources
Last reviewed: 10/07/19 by Milly Finch

An overview of the implementation of year 1 of the dose banding of chemotherapy CQUIN at Sheffield Teaching Hospitals.

Abstracts

View resources
Last reviewed: 10/07/19 by Louisa Knowles

The Impact of NHS England’s National Standardised Dose Banding for Adult Intravenous Systemic Anticancer Therapy at the Queen Elizabeth Hospital, Birmingham

Abstracts

View resources
Last reviewed: 10/07/19 by Rakesh Mattu

The safety of administering Bortezomib using haematological counts from the day of the previous administration

Abstracts

View resources
Last reviewed: 10/07/19 by Anne O’Connor

Understanding the Patient Preferences for Community Monitoring of Abiraterone: An analysis of new models involving community pharmacists.

Abstracts

View resources
Last reviewed: 10/07/19 by Melanie Dalby

User acceptability of a referral pathway to community pharmacy for patients on oral anticancer mediation

Abstracts

View resources
Last reviewed: 10/07/19 by Aishling McLoughlin

Ninety minute daratumumab infusion with a reduction in premedication is safe in multiple myeloma

Abstracts

View resources
Last reviewed: 09/02/23 by Sophie Harding

Non-medical prescribers (NMP) opinions and beliefs concerning non-medical prescribing current practice within oncology

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 37 38 39 … 43 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.